Nifty
Sensex
:
:
25377.55
82948.23
-41.00 (-0.16%)
-131.43 (-0.16%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 532649 | NSE: NECLIFE

31.50
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  31.01
  •  32.39
  •  31.01
  •  30.93
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2473097
  •  785.73
  •  56.50
  •  21.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,043.49
  • 169.87
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,659.22
  • N/A
  • 0.97

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 1.45%
  • 23.70%
  • FII
  • DII
  • Others
  • 16.6%
  • 0.02%
  • 2.43%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.24
  • -6.58
  • 0.30

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -5.50
  • -7.16
  • -0.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.77
  • -30.92
  • -41.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.47
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.54
  • 0.50
  • 0.56

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.89
  • 9.02
  • 10.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
359.30
394.12
-8.83%
441.38
388.81
13.52%
452.17
344.13
31.40%
397.96
388.65
2.40%
Expenses
319.50
358.58
-10.90%
392.87
370.73
5.97%
409.98
342.68
19.64%
371.10
396.04
-6.30%
EBITDA
39.80
35.54
11.99%
48.50
18.09
168.10%
42.19
1.45
2,809.66%
26.87
-7.40
-
EBIDTM
9.52%
7.88%
9.45%
4.05%
8.22%
0.37%
5.98%
-1.65%
Other Income
0.55
0.47
17.02%
1.47
17.93
-91.80%
0.48
13.24
-96.37%
10.61
10.71
-0.93%
Interest
19.98
17.62
13.39%
24.16
19.66
22.89%
24.84
17.46
42.27%
20.52
20.99
-2.24%
Depreciation
15.46
15.33
0.85%
14.70
14.85
-1.01%
15.37
14.78
3.99%
15.31
14.79
3.52%
PBT
4.92
3.06
60.78%
11.11
1.50
640.67%
2.46
-17.56
-
1.64
-32.47
-
Tax
1.95
1.24
57.26%
10.52
-2.17
-
0.89
-8.27
-
0.63
-10.00
-
PAT
2.97
1.82
63.19%
0.59
3.67
-83.92%
1.56
-9.29
-
1.02
-22.47
-
PATM
0.71%
0.40%
0.12%
0.82%
0.30%
-2.40%
0.23%
-5.02%
EPS
0.13
0.08
62.50%
0.03
0.16
-81.25%
0.07
-0.41
-
0.05
-1.00
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,650.81
1,684.09
1,523.67
1,668.83
1,543.30
2,366.38
2,782.86
1,876.26
1,643.70
1,675.69
1,643.64
Net Sales Growth
8.91%
10.53%
-8.70%
8.13%
-34.78%
-14.97%
48.32%
14.15%
-1.91%
1.95%
 
Cost Of Goods Sold
1,160.42
1,202.24
1,159.29
1,223.13
1,157.12
1,858.61
2,217.71
1,367.01
1,154.31
1,174.12
1,141.33
Gross Profit
490.39
481.85
364.38
445.70
386.19
507.77
565.16
509.25
489.39
501.57
502.31
GP Margin
29.71%
28.61%
23.91%
26.71%
25.02%
21.46%
20.31%
27.14%
29.77%
29.93%
30.56%
Total Expenditure
1,493.45
1,532.53
1,470.66
1,510.29
1,441.84
2,146.68
2,518.70
1,640.10
1,419.29
1,436.94
1,376.73
Power & Fuel Cost
-
129.52
127.39
101.41
84.63
92.72
103.47
91.85
75.44
87.89
79.60
% Of Sales
-
7.69%
8.36%
6.08%
5.48%
3.92%
3.72%
4.90%
4.59%
5.25%
4.84%
Employee Cost
-
81.71
75.14
71.91
70.59
78.19
76.55
74.65
75.54
78.38
58.93
% Of Sales
-
4.85%
4.93%
4.31%
4.57%
3.30%
2.75%
3.98%
4.60%
4.68%
3.59%
Manufacturing Exp.
-
56.12
45.32
45.56
44.64
46.88
50.38
52.90
53.32
39.56
37.05
% Of Sales
-
3.33%
2.97%
2.73%
2.89%
1.98%
1.81%
2.82%
3.24%
2.36%
2.25%
General & Admin Exp.
-
21.58
19.34
18.36
20.74
20.15
21.82
23.02
20.07
20.36
21.60
% Of Sales
-
1.28%
1.27%
1.10%
1.34%
0.85%
0.78%
1.23%
1.22%
1.22%
1.31%
Selling & Distn. Exp.
-
38.99
42.87
48.03
50.82
46.37
45.66
28.72
39.00
35.24
35.25
% Of Sales
-
2.32%
2.81%
2.88%
3.29%
1.96%
1.64%
1.53%
2.37%
2.10%
2.14%
Miscellaneous Exp.
-
2.37
1.32
1.90
13.31
3.76
3.12
1.95
1.61
1.41
35.25
% Of Sales
-
0.14%
0.09%
0.11%
0.86%
0.16%
0.11%
0.10%
0.10%
0.08%
0.18%
EBITDA
157.36
151.56
53.01
158.54
101.46
219.70
264.16
236.16
224.41
238.75
266.91
EBITDA Margin
9.53%
9.00%
3.48%
9.50%
6.57%
9.28%
9.49%
12.59%
13.65%
14.25%
16.24%
Other Income
13.11
24.33
53.06
11.32
11.38
4.36
6.04
6.04
22.67
5.78
20.00
Interest
89.50
96.89
89.36
78.81
112.03
125.83
148.13
115.20
117.41
123.31
125.59
Depreciation
60.84
60.72
59.12
56.97
60.25
60.77
63.26
64.31
62.25
57.39
76.56
PBT
20.13
18.27
-42.42
34.08
-59.45
37.47
58.82
62.68
67.42
63.83
84.75
Tax
13.99
13.27
-18.24
9.03
-11.50
5.68
11.22
10.41
12.08
9.59
18.49
Tax Rate
69.50%
72.63%
43.00%
26.50%
13.57%
15.16%
19.08%
16.61%
17.92%
15.02%
21.82%
PAT
6.14
5.00
-24.18
25.05
-73.26
31.79
47.60
52.27
55.34
54.24
66.26
PAT before Minority Interest
6.14
5.00
-24.18
25.05
-73.26
31.79
47.60
52.27
55.34
54.24
66.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.37%
0.30%
-1.59%
1.50%
-4.75%
1.34%
1.71%
2.79%
3.37%
3.24%
4.03%
PAT Growth
123.37%
-
-
-
-
-33.21%
-8.93%
-5.55%
2.03%
-18.14%
 
EPS
0.34
0.28
-1.36
1.40
-4.11
1.78
2.67
2.93
3.10
3.04
3.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,069.25
1,064.59
1,087.90
1,062.03
1,136.13
1,105.16
1,058.66
1,006.68
954.08
957.95
Share Capital
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
22.43
Total Reserves
1,046.82
1,042.17
1,065.48
1,039.60
1,113.70
1,082.73
1,036.23
984.25
931.65
935.52
Non-Current Liabilities
141.51
213.12
296.29
126.41
249.29
299.92
355.84
295.58
362.30
396.92
Secured Loans
126.68
213.16
280.80
127.46
120.00
164.40
218.21
161.20
243.44
264.36
Unsecured Loans
13.63
13.31
10.28
0.78
1.48
1.19
1.87
2.60
1.96
1.17
Long Term Provisions
7.94
6.45
6.39
7.74
8.20
9.36
9.07
8.49
6.91
6.01
Current Liabilities
972.82
890.93
1,003.83
1,187.39
1,247.89
1,299.91
1,309.32
1,278.66
1,239.95
1,155.60
Trade Payables
419.66
318.75
376.65
342.15
527.14
483.67
539.42
528.10
496.78
455.58
Other Current Liabilities
138.72
111.40
122.71
131.63
95.44
170.40
123.40
106.88
107.95
90.50
Short Term Borrowings
412.22
458.91
502.77
712.00
619.71
635.97
634.08
630.34
627.24
595.30
Short Term Provisions
2.22
1.86
1.70
1.61
5.59
9.87
12.41
13.34
7.98
14.22
Total Liabilities
2,183.58
2,168.64
2,388.02
2,375.83
2,633.31
2,704.99
2,723.82
2,580.92
2,556.33
2,510.47
Net Block
642.71
661.97
723.10
771.89
784.85
824.82
852.35
881.24
905.58
933.73
Gross Block
1,599.41
1,557.96
1,562.95
1,555.70
1,508.82
1,490.49
1,456.36
1,363.67
1,383.66
1,451.42
Accumulated Depreciation
956.71
895.99
839.85
783.81
723.97
665.68
604.00
482.43
478.08
517.69
Non Current Assets
899.75
937.46
1,033.18
1,137.01
1,018.15
1,035.96
1,063.21
1,085.05
1,091.92
1,105.54
Capital Work in Progress
65.75
77.78
85.10
98.63
115.00
99.55
99.79
102.11
99.35
91.31
Non Current Investment
0.24
0.24
0.24
0.24
0.24
0.27
0.27
0.27
0.27
0.15
Long Term Loans & Adv.
12.62
10.93
9.76
12.17
115.07
108.33
104.19
96.90
82.24
80.34
Other Non Current Assets
178.44
186.54
214.99
254.08
2.99
2.99
6.61
4.53
4.47
0.00
Current Assets
1,283.83
1,231.18
1,354.85
1,238.83
1,615.16
1,669.03
1,660.61
1,495.86
1,464.42
1,369.02
Current Investments
0.50
0.32
0.46
0.46
0.17
0.51
0.51
0.41
0.52
0.44
Inventories
709.15
672.60
659.86
587.89
977.55
917.97
859.43
854.65
836.71
790.98
Sundry Debtors
379.19
279.61
446.98
374.83
395.87
558.73
611.97
499.73
491.45
446.50
Cash & Bank
19.81
17.58
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38
Other Current Assets
175.19
96.05
67.05
51.67
220.28
170.50
179.38
127.89
99.09
97.73
Short Term Loans & Adv.
132.88
165.03
162.69
198.45
149.76
98.69
124.56
74.01
67.55
84.61
Net Current Assets
311.01
340.26
351.02
51.44
367.27
369.13
351.29
217.20
224.47
213.42
Total Assets
2,183.58
2,168.64
2,388.03
2,375.84
2,633.31
2,704.99
2,723.82
2,580.91
2,556.34
2,510.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
224.69
133.65
95.00
21.38
284.96
239.24
65.17
198.76
168.82
144.41
PBT
18.27
-42.42
34.08
-84.77
37.47
58.82
62.68
67.42
64.74
84.75
Adjustment
137.55
98.14
125.47
150.40
186.46
207.17
175.82
158.85
174.16
185.24
Changes in Working Capital
68.87
77.93
-64.54
-40.54
70.36
-13.19
-160.72
-20.34
-61.52
-119.29
Cash after chg. in Working capital
224.69
133.65
95.00
25.09
294.29
252.79
77.79
205.93
177.38
150.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
-3.71
-9.33
-13.56
-12.62
-7.17
-8.56
-6.29
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-17.02
51.70
16.64
-28.62
-33.13
-26.13
-29.43
-18.10
-76.88
-59.53
Net Fixed Assets
-29.42
12.31
6.28
-30.51
-33.78
-33.89
-90.37
17.23
59.72
-79.32
Net Investments
-0.18
0.47
0.00
-0.29
0.37
0.00
-0.10
0.11
-0.53
-0.23
Others
12.58
38.92
10.36
2.18
0.28
7.76
61.04
-35.44
-136.07
20.02
Cash from Financing Activity
-205.44
-185.58
-119.38
11.49
-251.87
-201.09
-39.60
-204.12
-88.68
-61.47
Net Cash Inflow / Outflow
2.23
-0.23
-7.73
4.25
-0.03
12.02
-3.87
-23.47
3.27
23.40
Opening Cash & Equivalents
17.58
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38
9.98
Closing Cash & Equivalent
19.81
17.58
17.81
25.54
21.29
21.33
9.31
13.18
36.65
33.38

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
47.68
47.47
48.51
47.36
50.66
49.28
47.21
44.89
42.54
41.11
ROA
0.23%
-1.06%
1.05%
-2.93%
1.19%
1.75%
1.97%
2.15%
2.14%
2.70%
ROE
0.47%
-2.25%
2.33%
-6.67%
2.84%
4.40%
5.06%
5.64%
5.78%
7.17%
ROCE
6.54%
2.49%
5.77%
1.41%
8.32%
10.29%
9.13%
9.73%
9.95%
11.58%
Fixed Asset Turnover
1.22
1.12
1.23
1.15
1.76
2.11
1.48
1.27
1.26
1.25
Receivable days
62.43
75.92
77.89
79.75
65.92
68.64
96.93
103.72
95.49
85.98
Inventory Days
130.94
139.23
118.26
161.98
130.89
104.21
149.46
176.99
165.71
161.85
Payable days
112.09
109.47
107.25
137.11
82.45
68.84
113.92
128.03
119.13
113.39
Cash Conversion Cycle
81.28
105.68
88.90
104.62
114.37
104.01
132.47
152.69
142.07
134.44
Total Debt/Equity
0.59
0.71
0.79
0.85
0.69
0.82
0.90
0.87
1.01
1.00
Interest Cover
1.19
0.53
1.43
0.24
1.30
1.40
1.54
1.57
1.52
1.67

News Update:


  • Nectar Lifesciences - Quarterly Results
    14th Aug 2024, 13:26 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.